Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-01

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Is Drainage Necessary After Total Hip Replacement?

NCT02562586

Osteoarthritis, Hip

COMPLETED NA

Tissue Sparing Surgery in Total Hip Arthroplasty

NCT04358250

Total Hip Arthroplasty Hip Arthrosis

COMPLETED NA

Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

NCT01468129

One-stage Bilateral Total Hip Replacement

UNKNOWN NA

Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing

NCT06410079

Hip Arthrosis Femur Head Necrosis

NOT_YET_RECRUITING

Preoperative Warming, Hypothermia and Functional Recovery in Total Hip Arthroplasty

NCT05213377

Hypothermia Following Anesthesia Hypothermia; Anesthesia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Revision of Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Use

Patients in whom the cell saver was effectively used

Use of Cell Salvage in revision of total hip arthroplasty

Intervention Type PROCEDURE

The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.

Not Use

Patients in whom the cell saver wasn't effectively used

Use of Cell Salvage in revision of total hip arthroplasty

Intervention Type PROCEDURE

The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of Cell Salvage in revision of total hip arthroplasty

The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible patients were adults undergoing elective aseptic revision of hip arthroplasty at the department of orthopedic surgery of the University Hospital of Liege between 01 January 2011 and 31 December 2020.